Caspofungin for invasive fungal infections: Combination treatment with liposomal amphotericin B in children undergoing hemopoietic stem cell transplantation
- 1 April 2005
- journal article
- case report
- Published by Wiley in Pediatric Transplantation
- Vol. 9 (2) , 254-257
- https://doi.org/10.1111/j.1399-3046.2005.00261.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Retrospective study of the safety of caspofungin in immunocompromised pediatric patientsThe Pediatric Infectious Disease Journal, 2003
- Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignanciesCancer, 2003
- Combination therapy with caspofungin and liposomal amphotericin B for invasive aspergillosisThe Pediatric Infectious Disease Journal, 2003
- Caspofungin therapy for Aspergillus lung infection in a boy with chronic granulomatous diseaseThe Pediatric Infectious Disease Journal, 2003
- Recent trends in the epidemiology of invasive mycosesCurrent Opinion in Infectious Diseases, 2002
- Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International ConsensusClinical Infectious Diseases, 2002
- Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropeniaPublished by Wiley ,2000
- Aspergillosis in Children with Cancer: A 34-Year ExperienceClinical Infectious Diseases, 1999
- Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 1999
- Pulmonary fungal infections in immunocompromised childrenCurrent Opinion in Pediatrics, 1997